Insiders who have reported open-market trades at the same companies as Holger Weis. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Holger Weis is a corporate insider, tracked as CEO of Alaunos Therapeutics, Inc. (TCRT). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Holger Weis submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
InsiderAlpha's records for Holger Weis go back to 2025: 11 primary Form 4 filings, an average of 5.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
